All Articles

CTM and Huawei just launched the world's first integrated QKD IP network in Macao. But is this hardware-heavy defense a blueprint or an expensive gamble?

As U.S. pet spending surges to a projected $165 billion, nebulous marketing claims are losing ground to verifiable nutritional science and supply chain transparency.

EHang is bypassing traditional aviation treaties to launch pilotless eVTOLs in Vietnam. Will municipal sandboxes fast-track Southeast Asia's aerial revolution?

Robbyant's new MoU with the Arab Federation for Digital Economy signals a massive shift. As Western markets tighten, Chinese embodied AI is finding its ultimate proving ground in the Middle East.

A massive €40 million seed round for an Italian biotech signals a paradigm shift in treating intractable genetic disorders like Fragile X Syndrome.

Dinari and Kakaopay Securities are bypassing legacy market friction to bring South Korean equities to the blockchain. Will this cure the Korea Discount?

A new strategic partnership between Evosep and Mass Dynamics aims to solve proteomics’ biggest bottleneck: pre-analytical variability in drug discovery.

Luxury Watch Works launches a unified Centre of Excellence in Mumbai, combining Swiss-authorised servicing, blockchain tracking, and lifecycle asset management.

As AI data centers drain local water supplies, MagPro’s new AeroLev 1850 magnetic-levitation chiller offers a zero-water, high-heat cooling lifeline.

As the cosmetic dentistry market booms, practitioners face a new challenge: untangling AI-generated health myths and fixing the hidden costs of at-home bleaching.

AstraZeneca’s $2 billion investment in Summit Therapeutics signals a structural shift in cancer care, uniting bispecifics and ADCs to dethrone incumbents.

Slate Asset Management's $2.34 billion REIT buyout proves that in an era of retail volatility, necessity-based assets are the ultimate defensive play.

As governments sign sweeping environmental frameworks, Hong Kong's EarthCare Foundation is bridging the gap with grassroots agri-tech and climate resilience.

Azurity's newly approved liquid lamotrigine isn't just a convenience—it's a critical safety measure for pediatric epilepsy and bipolar patients facing high risks.

As imported reusable bags pile up in landfills, a new Mississauga facility bets domestic automation can solve retail's post-plastic paradox.

As digital trading expands, unregulated brokers are weaponizing software partnerships and administrative filings to project false institutional credibility.

Commercial auto insurers face 14 years of losses. A new partnership aims to connect the missing two-thirds of light-to-medium fleets to stop the bleeding.

How two Sydney compounding pharmacists built a multi-million-unit wellness empire by weaponizing regulatory compliance and rejecting offshore manufacturing.

Rancho Mission Viejo releases 232 final homes in Rienda. As sales pause until 2027, buyers navigate high taxes, infrastructure lags, and climate tech realities.

A historic winter drought halved Vail Resorts' profits. Now, the ski giant is betting on algorithmic efficiency and dynamic pricing to protect its bottom line.